ACLA
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.
Lawmakers are still wrangling over whether to include these two key lab industry bills in an end-of-year spending package due to pass next week.
The AACC representative said that, as written, the exemption would not apply to large portions of laboratory-developed testing done at academic medical centers.
VALID Act's Passage Now Likely to Hinge on Inclusion in End-of-Year Federal Spending Package
Premium
Congress must address several healthcare-related provisions before the end of the year, potentially giving legislators another shot at LDT reform in 2022.
The grandfathering clause of the bill would allow labs to continue using existing LDTs as long as only minor modifications are made.